NIKTIMVO 9 mg/.18mL
axatilimab-csfr · INJECTION · Incyte Corporation
No Recall History
Plain English
NIKTIMVO is a injection containing axatilimab-csfr at 9 mg/.18mL, taken intravenous. Manufactured by Incyte Corporation.
Key Facts
- Brand Name
- NIKTIMVO
- Generic Name
- axatilimab-csfr
- NDC Code (Product)
50881-034- Manufacturer
- Incyte Corporation
- Strength
- 9 mg/.18mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761411
- Drug Class
- Colony Stimulating Factor-1 Receptor Blocker [EPC]
- Marketing Start
- 01/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is NIKTIMVO used for?
NIKTIMVO contains axatilimab-csfr. It is a injection taken intravenous. Consult your doctor for specific uses.
Is NIKTIMVO a controlled substance?
NIKTIMVO is not classified as a controlled substance by the DEA.
What is the generic name for NIKTIMVO?
The generic name for NIKTIMVO is axatilimab-csfr. There are no other listed brand versions of axatilimab-csfr.
What is the NDC code for NIKTIMVO 9 mg/.18mL?
The NDC (National Drug Code) for NIKTIMVO 9 mg/.18mL is 50881-034, listed by Incyte Corporation.
Other NIKTIMVO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)